Citation data

OpenAlex

Works that cite this article, indexed by OpenAlex.

15 resultsUpdated October 25, 2026
1

Immunogenicity, antibody persistence, and safety of the 60 μg hepatitis B vaccine in hemodialysis patients: a multicenter, randomized, double-blind, parallel-controlled trial

Expert Review of Vaccines 16(10) (2017)

Yongliang Feng; Xiǎohóng Shí; Jing Shi; Linying Gao; Guangming Liu; Yanpeng Cheng; Minghu Pan; Chunxia Li; Jun Wang; Xuxia Guo; Yawei Zhang; Xiaofeng Liang; Suping Wang

3

Hepatitis B vaccination in chronic kidney disease patients: a call for novel vaccines

Expert Review of Vaccines 13(11) (2014)

Alicja Ewa Grzegorzewska

4

The prevalence of occult hepatitis B virus (hbv) infection in a large multi-ethnic haemodialysis cohort

BMC Nephrology 16(1) (2015)

Luciana Sowole; Wendy Labbett; Mauli Patel; Aisling O’Riordan; Jennifer Cross; Andrew Davenport; Tanzina Haque

5

Hepatitis B Vaccination in Advanced Chronic Kidney Disease: A Quality Improvement Project at a Veteran Affairs Chronic Kidney Disease Clinic

Infectious Disease Reports 13(4) (2021)

Jacob A. Hettenbaugh; Ryan Mullane; Gayle Gillispie; Valerie Shostrom; Linda Flores; Jennifer A. Fillaus; Marius C. Florescu; Denise Murcek; Ketki K. Tendulkar

6

Long-term persistent immunogenicity after successful standard and triple-dosed hepatitis B vaccine in hemodialysis patients: A 3-year follow-up study in China

Vaccine 39(18) (2021)

Yao Tian; Zhihong Shao; Lina Wu; Shuang Dong; Linying Gao; Yuan-Ting Wu; Xiǎohóng Shí; Jing Shi; Guangming Liu; Jianmin Wang; Huilin Zhao; Hongping Guo; Hongting Liu; Xiaofeng Wu; Liming Liu; Xiaohui Song; Jiangtao Zhu; Yawei Zhang; Yongliang Feng; Xiaofeng Liang; Suping Wang

7

Variables linked to hepatitis B vaccination success in non-dialyzed chronic kidney disease patients: Use of a bayesian model

Néphrologie & Thérapeutique 15(4) (2019)

Yves Dimitrov; Michel Ducher; Marc Kribs; Guillaume Laurent; Sarah Richter; Jean‐Pierre Fauvel

8

Immunogenicity and safety of a high-dose and prolonged-schedule hepatitis B vaccine among chronic kidney disease patients: a randomized, parallel-controlled trial

Expert Review of Vaccines 20(6) (2021)

Yongliang Feng; Tian Yao; Yujie Han; Jing Shi; Shuang Dong; Yuan-Ting Wu; Zhihong Shao; Hongting Liu; Hongping Guo; Guowei Chai; Liming Liu; Fuzhen Wang; Jianmin Wang; Xiaofeng Liang; Suping Wang

9

Barriers to vaccination in renal transplant recipients

Transplant Infectious Disease 19(5) (2017)

Angela Q. Maldonado; David Johnson; Jennifer Trofe‐Clark

10

Duration of immunogenicity of high-dose and prolonged-schedule hepatitis B vaccine among patients with chronic kidney disease: A one year follow-up study in China

Expert Review of Vaccines 21(11) (2022)

Yujie Han; Na Cao; Xiaoxiao Lu; Tian Yao; Jing Shi; Yuan-Ting Wu; Shuang Dong; Zhihong Shao; Jianmin Wang; Hongting Liu; Hongping Guo; Guowei Chai; Liming Liu; Fuzhen Wang; Yongliang Feng; Xiaofeng Liang; Suping Wang

11

Immunogenicity, Safety, and Persistence Induced by Triple- and Standard-Strength 4-Dose Hepatitis B Vaccination Regimens in Patients Receiving Hemodialysis

The Journal of Infectious Diseases 231(4) (2024)

Yao Tian; Yandi Li; Yidan Zhang; Yangle Sun; Yana Guo; Jianmin Wang; Xiaohui Song; Wei Zhang; Baozhu Wei; Jingen Bai; Hui Wang; Weimin Yu; Huiyuan Wang; Jiao Lu; Yinqiang Diao; Liming Liu; Shuaishuai Shi; Jie Yang; Xiaojun Ren; Wenyuan Liu; Jingai Fang; Xiaofeng Liang; Suping Wang; Yongliang Feng

13

Seroprotection achieved with standard four-dose schedule of hepatitis B vaccine in people with chronic kidney disease: A real-life data

Indian Journal of Gastroenterology 44(1) (2024)

Surender Singh; Ajay Kumar Mishra; Monika Yachha; Thakur Prashant Singh; Harshita Katiyar; Anupma Kaul; Radha Krishan Dhiman; DHARMENDRA SINGH BHADAURIA; Amit Goel

14

Three Doses of Hepatitis B Vaccine or Four Doses in Chronic Renal Failure

Hepatitis Monthly 13(3) (2013)

Zahra Khazaeipour; Farokhlagha Ahmadi

15

Decreasing High Failure Rate of Vaccinations in Patients With Chronic Kidney Disease; not Just a Matter of Quantity

Hepatitis Monthly 12(7) (2012)

Theodoros Eleftheriadis; Vassilios Liakopoulos; Ioannis Stefanidis